Ironwood Pharmaceuticals IRWD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $40.77M+209% | $0-100% | $40.08M+999% | $23.6M+2,844% | -$37.39M-798% | ||
| $443K-7.5% | $460K-5.2% | $475K-6.3% | $467K-7.7% | $479K-6.6% | ||
| $3.65M-31.0% | $3.82M-16.3% | $3.61M-56.6% | $4.52M-47.2% | $5.29M-36.9% | ||
| $5.12M-74.3% | $74.58M+390% | $47.58M+381% | —— | $19.95M-55.6% | ||
| —— | $0— | $2K-87.5% | $2K-96.6% | $31K-54.4% | ||
| —— | $0— | -$2K+87.5% | -$2K+96.6% | -$31K+54.4% | ||
| —— | $122K+101% | $0+100% | $88K+100% | $6K+100% | ||
| $5.02M-74.8% | $75.05M— | $47.56M+375% | —— | $19.92M-32.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
